w w w . j c o l . o r g . b r
Journal
of
Coloproctology
Original
Article
Immunohistochemical
study
of
the
canonical
and
non-canonical
Wnt
signaling
pathway
in
colorectal
carcinoma
and
non-neoplastic
mucosa
夽
Rodrigo
Felippe
Ramos
a,∗,
Celina
Tizuko
Fujyiama
Oshima
b,
Thiago
Simão
Gomes
b,
Ana
Maria
Amaral
Antonio
Mader
c,
Caio
Dal
Moro
Alves
d,
Jaques
Waisberg
d aDepartmentofSurgery,UniversidadeFederalFluminense(UFF),Niterói,RJ,BrazilbDepartmentofPathology,EscolaPaulistadeMedicina(EPM),UniversidadeFederaldeSãoPaulo(UNIFESP),SãoPaulo,SP,Brazil
cDepartmentofPathology,FaculdadedeMedicinadoABC(FMABC),SantoAndré,SP,Brazil
dDepartmentofSurgery,EscolaPaulistadeMedicina(EPM),UniversidadeFederaldeSãoPaulo(UNIFESP),SãoPaulo,SP,Brazil
a
r
t
i
c
l
e
i
n
f
o
Articlehistory: Received3March2015 Accepted8June2015 Availableonline8July2015
Keywords:
Colorectalneoplasms Wntproteins Frizzledreceptors Axinsignalingcomplex Immunohistochemistry
a
b
s
t
r
a
c
t
ColorectalcancerislinkedtoseveralsignalingpathwayssuchasWntpathway.Our objec-tiveistodetectandverifytheintegrityofproteinmembersofWntsignalingpathwayin colorectalcarcinomaandnon-neoplasticcolorectaltissue.Sixty-fourpatientswith colorec-talcarcinomaprovidedsamplesofcolorectalneoplasiaandnon-neoplastictissues,which werepreparedintissuemicroarrayblocksandsubjectedtoimmunohistochemicalanalysis. TheprimaryantibodiesusedwereWnt-1,Wnt-2,Wnt-5aFrizzled-1,Frizzled-5andaxin. ImmunoexpressionofWnt-2proteinwassignificantlylowerincolorectaltumortissueand axinproteinimmunoexpressionwassignificantlyhigherintumortissue.Therewasno sig-nificantdifferenceintheexpressionofWnt-1,Wnt-5a,Frizzled-1andFrizzled-5proteins inbothtissues.ThehigherexpressionofWnt-2proteininnon-neoplasticcolorectal tis-suesuggeststheparticipationduringthehyperproliferativestageofcolorectalmucosa.The increasedaxinproteinimmunoexpressionincolorectaltumorsuggestsadecreaseinthe formationofthe-catenindestructorcomplex.
©2015SociedadeBrasileiradeColoproctologia.PublishedbyElsevierEditoraLtda.All rightsreserved.
Estudo
imunoistoquímico
da
via
de
sinalizac¸ão
canônica
e
não
canônica
da
proteína
Wnt
em
carcinoma
colorretal
e
em
mucosa
não
neoplásica
Palavras-chave: Neoplasiascolorretais
r
e
s
u
m
o
Ocâncercolorretalestáligadoaváriasviasdesinalizac¸ão,comoaviaWnt.Nossoobjetivo édetectareverificaraintegridadedasproteínasdaviadesinalizac¸ãoWntnocarcinoma
夽
StudycarriedoutattheInterdisciplinarySurgicalSciencePost-GraduationProgram,EscolaPaulistadeMedicina(EPM),Universidade FederaldeSãoPaulo(UNIFESP)intheLaboratoryofExperimentalMolecularPathology,DepartmentofPathology.
∗ Correspondingauthor.
E-mail:rofelippe@terra.com.br(R.F.Ramos).
http://dx.doi.org/10.1016/j.jcol.2015.06.002
ProteínasWnt Receptoresfrizzled Complexodesinalizac¸ãoda axina
Imunoistoquímica
colorretalenotecidocolorretalnãoneoplásico.Sessentaequatropacientescom carci-nomacolorretalforneceramamostrasdeneoplasiaetecidosnãoneoplásicos,queforam colocadasemblocosdetissuemicroarrayesubmetidasàanáliseimuno-histoquímica.Os anticorposprimáriosutilizadosforamWnt-1,Wnt-2,Wnt-5aFrizzled-1,Frizzled-5eaxina. AimunoexpressãodaproteínaWnt-2foisignificativamentemenornotecidotumoralea imunoexpressãodaproteínaaxinafoisignificativamentesuperiornotecidodotumor.Não houvediferenc¸asignificativanaexpressãodeWnt-1,Wnt-5a,frizzled-1enasproteínas Friz-zled1e5emambosostecidos.AmaiorexpressãodeWnt-2daproteínanotecidocolorretal nãoneoplásicosugereaparticipac¸ãodestaproteínaduranteoestágiodehiperproliferac¸ão damucosacolorretal.Oaumentodaimunoexpressãodaproteínaaxinanotumorcolorretal sugereumadiminuic¸ãonaformac¸ãodocomplexodedestruic¸ãodaproteína-catenina.
©2015SociedadeBrasileiradeColoproctologia.PublicadoporElsevierEditoraLtda. Todososdireitosreservados.
Introduction
Worldwide,colorectalcancer(CRC)isthethirdmostcommon
malignancyinmenandthesecondmostcommoninwomen.1
In the lower portion ofthe crypts of Lieberkühn, there
arestemcellsthatareresponsiblefortheproliferation, dif-ferentiationandself-renewingofthecolonepithelium.2The
maintenanceofthestemcellcompartmentandthetransition
fromproliferationtodifferentiationareregulatedbyWntcell signalingreceptors(Winglessandwnt-relatedprotein).3
The Wnt pathway acts during embryogenesis in
verte-brates and invertebrates and in the regulation of cellular
proliferation,differentiationandapoptosis.4
Frizzled,LRP(low-densitylipoproteinreceptor-related pro-tein)5andLRP6areparticipatingreceptorsinthecanonical Wntsignalingpathway,inducingstabilizationofthe-catenin
protein in the cytoplasm. This regulation of stability is
mediatedbytheAPC(adenomatouspolyposiscoli)tumor
sup-pressorgenethroughacomplexofproteinsthatalsoincludes,
axin, GSK3 (glycogen synthase kinase 3) and CK1 (casein
kinase1),whichformtheso-calleddestructorcomplexof -catenin. Axin/-catenininteraction isan importantcontrol pointfortheWntpathwaythatplaysaroleintumorgenesis.5 Theincreaseinthepoolof-catenininthecytoplasmbyWnt stimulationoccursduetoblockingofthedestructorcomplex bytheDisheveled(Dsh)protein,mediatingthetranscription
ofWnttargetgenesinthenucleus.6Deletionsormutations
intheaxingenehavebeenobservedinvarioustumortypes,
includingCRCandhepatocellularcarcinoma.7
Thenon-canonicalpathwayisagenerictermforallWnt
signaling pathways that promote transcription that is not
mediatedby-catenin8andisactivatedbyFrizzledreceptors independentlyoftheactivationofLRP5andLRP6.
Thecanonicalpathwayhasreceivedconsiderable
atten-tionovertheyearsduetoitsessentialroleinthehomeostasis
ofthecolonepitheliumandinthegenesisofCRC.However,
themechanismsofactionofthenon-canonicalWntsignaling
pathwayinCRCarenotyetcompletelyunderstood.9
In mammals, 19 types of Wnt proteins have been
described.9SomeWntproteinssuchasWnt-3andWnt-1can
activateboththecanonicalpathwayandthenon-canonical
pathway,whileothers,suchasWnt-5aprotein,appeartobe
specifictothenon-canonicalpathway.8Frizzledreceptorscan receivesignalsfromoneormoreproteinsoftheWntpathway, suchastheFrizzled-5receptor,whichreceivessignalsfrom
boththecanonicalpathway(Wnt-2) andthenon-canonical
pathway(Wnt-5a).10
InCRC, Wnt-1 andWnt-2proteinsare considered
stim-ulators of carcinogenesis,11,12 whereas the Wnt-5a protein
appearstohavetumorsuppressorcharacteristics.10However, therealroleofFrizzledreceptorsincolorectalcarcinogenesis remainsobscure.13
IdentificationofregulatoryproteinsinvolvedintheWnt
pathway offers opportunities to develop new therapies
directedatCRC14,15usingmonoclonalantibodiesagainst
ther-apeutic targets suchastheWnt-1 andWnt-2 proteinsand
for the axin protein and Frizzled receptors.16 De Almeida
etal.17showedthatasolublebiologicalreceptorwascapable ofblockingtheautocrineWntsignalinvitro,andexperiments
inmiceshowednosignsoftoxicityafterseveralweeks.He
etal.18developedamonoclonalantibodycapableofblocking
theWnt-1proteinandobservedincreasedapoptosisinCRC
celllines.AlthoughstillinphaseI,thesestudieshavealready
demonstratedthattheuseoftheWntsignalingpathwayasa
possibletherapeutictargetispromising.
Theaimofthisstudywastoinvestigatethecanonicaland
non-canonicalpathwaysofWntsignalingincolorectal
carci-nomaandadjacentnon-neoplasticcolorectalmucosathrough
theimmunoexpressionofWnt-1,Wnt-2,Wnt-5a,Frizzled-1,
andFrizzled-5andaxinproteins.
Method
Samples
ThisstudywasapprovedbytheResearchEthicsCommitteesof
theparticipatinginstitutions.Thestudywasconductedusing
samples from 64 patients with CRC who underwent
cura-tiveorpalliativesurgery.Thirty-four(53%)patientsweremen
and30(47%)werewomen.Themedianagewas69.2(range,
41–94years).Colorectaltissuesampleswereobtainedfrom64 patientswhounderwentsurgeryforCRCandweredividedinto
B– tissuesamplesobtainedfrom non-neoplasticcolorectal
mucosalocated10cmcranialtothetumor.
Histopathologicalanalysis
TissuesamplesfromCRCandnon-neoplasticcolorectal
tis-sueswere fixedin10% formalinand embeddedinparaffin
blocksforhistologicalanalysis.Conventionalhistological sec-tionswerepreparedfromeachblockat3-mthick.Allofthe
slideswerestainedwithhematoxylin–eosin(HE)andreviewed
byapathologistforconfirmationofthediagnosis.To charac-terizethehistology,thehistologicalgradeofthemalignancy accordingtotheInternational ClassificationofDiseasesfor
Oncology(ICD-O)wasused.
Inthe HE-stained slides,the surgicalmarginsand
best-preserved areas most representative of the tumor were
marked toobtain the cylinderused in TMA(tissue
micro-array). Areas of necrosis, hemorrhage and areas with low
cellularitywereexcluded.Next,theblockswereseparatedto verifythequalityandquantityofthetissuetobeusedand
tomarktheareasforbiopsy.TheTMAblockswereprepared
usingaBeecherdevice (BeecherInstruments,SilverSpring,
MD,USA).
Immunohistochemistry
For immunohistochemical studies, the streptavidin-biotin
technique(LSAB-DakoCytomation, CA,USA) wasused. The
polyclonalantibodiesusedwereasfollows:Wnt-1(G-19)(goat)
(R&DSystems, Minneapolis,MN,USA), Wnt-2 (H-20) (goat)
(R&DSystems, Minneapolis,MN,USA), Wnt-5a(goat) (R&D Systems,Minneapolis,MN,USA),Frizzled-1(F-13)(goat)(R&D Systems,Minneapolis,MN,USA),Frizzled-5(L-12)(goat)(R&D Systems,Minneapolis,MN,USA)andaxin(H-98)(rabbit)(1:100 SantaCruzBiotechnologyInc.,CA,USA).Alloftheantibodies wereusedata1:100dilution.
For immunohistochemicalstudies,4-mthick
histologi-calsectionswerepreparedaccordingtopreviouslydescribed
techniques.19Incubationwiththeantibodieswasperformed
in amoist incubation chamberat 4◦C for atleast 16–18h
(overnight).AfterthreewashesinPBSbufferpH7.2–7.6,
fur-therincubationwasperformedwithbiotinylatedsecondary
antibody(LSAB-DakoCytomation, CA, USA)in ahumidified
chamberatroomtemperaturefor30min.Subsequently,the
same process was performed using a
streptavidin-biotin-peroxidase kit (LSAB-DakoCytomation, CA, USA). Washes
were then madewith PBS buffer pH7.2–7.6,and the color
wasdevelopedwithliquidDAB(DakoCytomation,CA,USA)at
roomtemperaturefor5min.Afterwashinginrunningwater
for3min,counter-stainingwasperformedusingHarris hema-toxylinfor1min.Thesectionsweredehydratedin3absolute
ethanolbaths and 3xylenebaths and thenmounted with
cover slipsusingEntellan resin (SigmaChemical Co.,Saint
Louis,MO,USA)foranalysisinanopticalmicroscope.
The immunoreactivity of the Wnt-1, Wnt-2, Wnt-5a,
Frizzled-1,Frizzled-5proteinsandaxinwasanalyzedbased
on the proportion of the number of positive cells
(per-centageofpositivity)and the intensity of immunostaining
accordingtoastandardizedscale.Thepercentageofpositive cells orpositivitywas classified asfollows:zero=less than
5% immunostainedepithelial cells of the lesion;1=5–25%;
2=26–50%;3=51–75%;and4=morethan76%immunostained
epithelial cells in the lesion. The intensity of
immunoex-pression was evaluated as follows: 0=negative; 1+=weak;
2+=moderate;and3+=strong.Thefinalscorewascalculated bymultiplyingthescoreofthepercentageofpositivitybythe scoreforthereactionintensity.Thefinalscorewasclassified asreducedexpression(scorevaluebetween0and8)orstrong expression(scorevaluebetween9and12).20
Alloftheslideswereanalyzedbytwoindependent
exam-iners considering only the degree of immunostaining and
withoutaccesstoorknowledgeoftheanatomopathological
data.Incasesofdiscrepancyintheevaluation,theslideswere
re-evaluated,andaconsensusevaluationwasobtained.
Clinicalandanatomopathologicaldata
The following clinical and anatomopathological data were
collected from the medical records of the patients:
clin-ical characteristics (age, gender, ethnicity), macroscopic
tumorcharacteristics(location,appearance,size),microscopic characteristics (lymphnode invasion,degreeofcellular dif-ferentiation,andvenous,lymphaticandneuralinfiltration),
TNM21 classification, presenceof synchronousmetastases,
andtissueimmunoexpressionoftheantibodiesused
(percent-ageofpositivityandintensityofimmunoexpression).
Statisticalstudy
Quantitative results were reported as the median and
standarddeviation.Qualitativedataweredescribedaccording tothefrequencyofdistribution.Associationsbetweena pro-tein’spositivityandtheclinicopathologicalcharacteristicsof interestwereevaluatedusingFisher’sexacttest.Thelevelof significanceadoptedwas5%(p≤0.05).Statisticalanalysiswas
performedusing SPSSsoftwareversion15.0(ThePredictive
AnalyticsCompany,Chicago,IL,USA).
Results
Fifty-nine patients (92.2%)underwent curativesurgery, and
5patients(7.8%)underwentpalliativesurgery.TheCRCwas
locatedinthecolonin40patients(62.5%)andintherectum
in24patients(37.5%).Neoadjuvanttherapywasadministered
in 10 patients (15.6%), all of whom had rectal carcinoma.
The average size of a colorectal neoplasm was 5.2 (range,
0.5–12cm).Thesizeofthelesioninitslargestdiameterwas >5cmin43patients(67.1%)and≤5cmin21patients(32.8%).
Lymphnodemetastasiswasdetectedin31cases(48.4%),while
33patients(51.6%)hadlymphnodesfreeofany
compromis-ingneoplasm.Venousvascularinvasionwasobservedin21
patients(32.8%),lymphatic vascularinvasionin24patients
(37.5%) and neural invasionin 12 patients(18.7%). In
rela-tiontothedegreeofcellulardifferentiation,11cases(17.2%)
were classified as well-differentiatedcarcinomas, 51 cases
(79.7%) as moderately differentiated and 2 cases (3.1%) as
poorly differentiated. The CRC had infiltrated superficially
Table1–Frequencyofimmunoreactivityscoresofnon-neoplasticcolorectaltissuesandcolorectalcarcinoma.
Proteinexpression NNCRT CRC pvalue
Strong Weak Strong Weak
Wnt-1 3/53(5.6%) 50/53(94.4%) 2/58(3.4%) 56/58(96.6%) 1.00
Wnt-2 19/60(33.3%) 41/60(66.7%) 10/62(16.1%) 52/62(83.9%) 0.05
Wnt-5a 0 49/49(100%) 0 58/58(100%) 0.28
Frizzled-1 4/52(7.7%) 48/52(92.3%) 3/42(7.2%) 39/42(92.8%) 0.70
Frizzled-5 0 50/50(100%) 0 61/61(100%) 0.35
Axin 13/49(26.5%) 26/49(73.5%) 34/61(55.7%) 27/61(44.3%) 0.04
NNCRT,non-neoplasticcolorectaltissue;CRC,colorectalcarcinoma;pvalueobtainedwithFisher’sexacttest.
metastasesintheliverand/orotherlocationswereobserved in14 cases(21.9%).Relapseoccurred in13patients(20.3%), and12patients(18.7%)died.Theaveragefollow-uptimewas 19.1months(range,3–36months).
ImmunoexpressionoftheWnt-1proteininnon-neoplastic
colorectal tissue and colorectal carcinoma showed no
sig-nificantdifference(p=1.0).ImmunoexpressionoftheWnt-2
protein in colorectal carcinoma was significantly lower
(p=0.05)thaninnon-neoplasticcolorectaltissue(Table1and
Fig. 1). Immunoexpression of the Wnt-5a protein in
non-neoplasticcolorectaltissueandcolorectalcarcinomashowed
no significant difference (p=0.28) between them.
Immuno-expressionoftheFrizzled-1andFrizzled-5proteinsshowed
no significant differences (p=0.7 and p=0.35,respectively).
Axin protein immunoexpression was significantly reduced
(p=0.039)innon-neoplasticcolorectaltissuerelativeto neo-plastictissue(Table1andFig.2).
Discussion
DespitetheevidenceonWntproteinsandtheirFrizzled recep-torsandtheirparticipationincolorectalcarcinogenesis,the interactionsandregulatorymechanismsoftheseproteinsare notcompletelyunderstood.22Severalmutationsinoncogenes,
Fig.1–Photomicrographofcolorectalcarcinomawith positiveimmunoreactivityforWnt-2antibodyinthe cytoplasmoftumorcells(immunohistochemistry;200×).
Fig.2–Photomicrographofcolorectalcarcinomawith positiveimmunoreactivityantibodyaxininthecytoplasm oftumorcells(immunohistochemistry;100×).
tumor suppressor genes and other proteinsthat comprise
thesignaltransductionpathwayshavebeenassociatedwith
colorectalneoplasias.However,fewofthesemutations,when
known,occurinalltumorsandatallstagesofthedisease.
Although Wnt-1 isone ofthe moststudied proteinsof
thecanonicalWntsignalingpathway,thereare fewstudies
showingtheexpressionofthisproteinincolorectaltissues. Stanczaketal.23showedincreasedexpressionofWnt-1
pro-teininnormalcolorectalmucosaanddecreasedexpressionof
thisproteinintumortissue.Holcombeetal.11foundabundant
expressionofWnt-1proteininnormalmucosaandcolorectal
tumortissue.Inthepresentstudy,nosignificantdifference
wasfoundwhentheexpressionofWnt-1innon-neoplastic
colorectaltissuewascomparedwithcolorectaltumortissue.
Theseconflictingresultscouldsuggestthatothermechanisms maybeinvolvedincolorectalcarcinogenesisinadditiontothe activationofWnt-1protein.
Wnt-2proteinisanimportantinduceroftheWntcanonical signalingpathway.22 Otherauthors11,12 haveshownlittleor
eventheabsenceofexpressioninnormalcolorectalmucosa
butincreasedimmunoexpressionincolorectaltumortissue.
ThecurrentstudyshowedstrongexpressionofWnt-2protein
Of the proteins involved in the non-canonical Wnt
signaling pathway,Wnt-5a proteinappearstohave
tumor-suppressor behavior primarily for its ability to inhibit the
canonicalWntsignalingpathwayandreducethepoolof
-cateninproteininthe cytoplasm.10 Dejmeket al.24showed thatexpressionofWnt-5aisassociatedwithanincreased
five-yearsurvivalinpatientswithDukes’stageBCRC. Previous
studies11,22usingRT-PCRfoundWnt-5aproteinexpressionin normalcell lines,particularlyatthe baseofthe crypts,but
notin CRC tissues. Thepresent sampling,however, found
markedlyreducedexpressionofWnt-5aproteininboth
neo-plasticandnon-neoplasticcolorectaltissues.Thisfactcanbe explainedbytheuseofnon-neoplastictissuesfromthesame
patientsascontrolsbecauseithasbeendemonstratedthat
lossofWnt-5agenestimulatesthecanonicalWntsignaling
pathwayinpatientswithCRC.25Dejmeketal.24suggestedthat expressionofWnt-5aproteininpatientswithCRCseemstobe associatedwiththeearlystagesofneoplasia,aresultdifferent fromthefindingsofthepresentstudyinwhichthemajority ofpatientswereinthemoreadvancedstagesofCRC.
TheinteractionofWntproteinswithFrizzledreceptorsis consideredcrucialtotheunderstandingofWntsignaling,both
inembryogenesisandindevelopmentoftumors.19 Despite
intensiveresearchinto theWntsignaling pathwayandthe
participationofitsconstitutiveproteins,26theroleofthe Friz-zledproteinsinthisconditionremainsunclear.Fewstudies
haveexaminedtheexpressionofFrizzledreceptorsin
colo-rectal tissue. You et al.27 observedthat the Frizzled-1and
Frizzled-2receptorswereoverexpressedindysplasticmucosa
adjacenttoCRC,underexpressedinnormalmucosaandnot
expressedinneoplastictissue.InpatientswithsporadicCRC, Holcombeetal.11foundexpressionofFrizzled-1and Frizzled-2receptorsonlyinpatientswithpoorlydifferentiatedlesions, suggestingthattheregulationoftheFrizzledproteinsisan importantstepintheprocessoftumorinvasion.Inthepresent
study,both the Frizzled-1and Frizzled-5receptorsshowed
decreasedexpressioninnon-neoplasticcolorectaltissueand CRC.
Theaxingeneactsasatumorsuppressorgenethrougha
negativefeedbacksystem,regulatingthesignalresponsesof
theWntsignalingpathway.28Normally,axinproteinreduces
thelevelsof-catenininthecytoplasm.However,mutations
inthis geneleadto anincreaseinthe concentrationof
-catenin in colorectal tumors. Jin et al.29 analyzed 54 CRC
specimensfrompatientsandfoundthat11%hadaxingene
mutations, suggesting that this change may be associated
withcolorectal carcinogenesis.Websteret al.30 studiedthe axingenein4differentCRCcelllinesandshowedthat muta-tionofthisgenealtersitsbindingcapacitytotheGSK3gene
thereby preventingthe formation ofthe destructorprotein
complexof-catenin.
Thus,abnormallyhighlevelsofaxinproteinexpressioncan maskafunctionaldifferencebecausethelevelsofexpression ofthisgenetendtobelow.5Suchaneffectmayexplainthe factthatstrongexpressionofthisproteinintumortissuewas
foundinthisstudy,whilereducedexpressionwasfoundin
non-neoplasticcolorectal tissue,afinding alsoobservedby
HughesandBrady.28
Someofthedifferencesfoundinthe resultsofthe
cur-rentstudy,whencomparedwiththosefoundintheliterature,
canbeexplainedbyfactorsrelatedtothemethodusedinthe research.Moststudies15,16,27usedanRT-PCRmethod,whereas
the current study used an immunohistochemical method.
Another importantfactor wastheuse oftissueculturecell
linesforanalysisinthesestudies.Otherauthors12,26showed
differences in the expression ofproteins inneoplastic
tis-suesofpatientscomparedwiththesametumorcelllinefrom
tissue culture.Moresophisticated methodssuchas insitu
hybridization or laser capture microdissection(LCM) could
betterelucidatetheseissues.
Thus, in the present study, differentdegrees of
expres-sion of Wnt, Frizzled receptors and axin proteins were
found inneoplastic colorectal tissuescompared with
non-neoplastictissues,findingsthatwerealsoobservedbyother authors.11,12,23,26BecausetheWntsignalingpathwayandAPC
gene11 pathwayactinthetransformationofnormal
epithe-liumintoproliferativeepithelium,itispossiblethatmostof
theproteinsofthesepathwaysinvolvedintumorigenesisare
expressedbothinthetumortissueandintheadjacentmucosa
ofthesesametumors.
Theresultsshowingtheabsenceofincreasedexpressionof
proteinsofthenon-canonicalWntpathway(Wnt-1,Wnt-5a,
Frizzled-1andFrizzled-5)suggestthatthisrouteisnotfully enabledinsporadicCRC,andthereforecontributeslesstothe
genesis ofCRC. However,the Wnt-2protein, typicalofthe
canonicalWntsignalingpathway,showedasignificant
differ-encebetweenthelevelsofimmunohistochemicalexpression
in non-neoplastic colorectal tissue and tumor tissue. The
higherexpressionofWnt-2proteininnon-neoplastic
colo-rectaltissuesuggeststheparticipationoftheproto-oncogene Wnt-2duringtheearlyand/orhyperproliferativestageof
pre-neoplasticchangesofthecolorectalmucosa.
Conflicts
of
interest
Theauthorsdeclarenoconflictsofinterest.
Acknowledgment
TheauthorsthankFundac¸ãodeAmparoàPesquisadoEstado
deSãoPaulo(FAPESP)forfinancialsupport.
r
e
f
e
r
e
n
c
e
s
1.FerlayJ,ShinHL,BrayF,FormanD,MathersC,ParkinDM. Estimatesofworldwideburdenofcancer2008:GLOBOCAM 2008.IntJCancer.2010;127:2893–917.
2.Ricci-VitianiL,FabriziE,PalioE,DeMariaR.Coloncancer stemcells.JMolMed.2009;87:1097–104.
3.FevrT,RobineS,LouvardD,HuelskenJ.Wnt/beta-cateninis essentialforintestinalhomeostasisandmaintenanceof intestinalstemcells.MolCellBiol.2007;27:7551–9.
4.MoonRT.Wnt/beta-cateninpathway.SciSTKE.2005;271:1–3.
5.ParveenN,HussainMU,PandithAA,MudassarS.Diversityof axininsignalingpathwaysanditsrelationtocolorectal cancer.MedOncol.2011;28:S259–67.
axinstabilityandWnt/-cateninsignaling.MolCellBiol. 2011;31:2053–65.
7. CadiganKM.Wnt/beta-cateninsignaling:turningtheswitch. DevCell.2008;14:322–3.
8. McDonaldSL,SilverA.TheopposingrolesofWnt-5ain cancer.BrJCancer.2009;101:209–14.
9. NusseR.Wntsignaling.ColdSpringHarbPerspectBiol. 2012;4:a011163.
10.TopolL,JiangX,ChoiH,Garrett-BealL,CarolanPJ,YangY. Wnt-5ainhibitsthecanonicalWntpathwaybypromoting GSK-3-independent-catenindegradation.JCellBiol. 2003;162:899–908.
11.HolcombeRF,MarshJL,WatermanML,LinF,MilovanovicT, TruongT.ExpressionofWntligandsandFrizzledreceptorsin colonicmucosaandincoloncarcinoma.MolPathol.
2002;55:220–6.
12.ViderBZ,ZimberA,ChastreE,PrevotS,GespachC,EstleinD, etal.EvidencefortheinvolvementoftheWnt2genein humancolorectalcancer.Oncogene.1996;12:153–8.
13.BurnsCJ,ZhangJ,BrownEC,VanBibberAM,VanEsJ,Clevers H,etal.InvestigationofFrizzled-5duringembryonicneural developmentinmouse.DevDyn.2008;237:1614–26.
14.UenoK,HiuraM,SuehiroY,HazamaS,HirataH,OkaM,etal. Frizzled-7asapotentialtherapeutictargetincolorectal cancer.Neoplasia.2008;10:697–705.
15.LuuHH,ZhangR,HaydonRC,RayburnE,KangQ,SiW,etal. Wnt/-cateninsignalingpathwayasnovelcancerdrug targets.CurrCancerDrugTargets.2004;4:653–71.
16.CurtinJC,LorenziMV.Drugdiscoveryapproachestotarget Wntsignalingincancerstemcells.Oncotarget.2010;1:563–77.
17.DeAlmeidaVI,MiaoL,ErnstJA,KoeppenH,PolakisP, RubinfeldB.ThesolublewntreceptorFrizzled8CRD-hFc inhibitsthegrowthofteratocarcinomasinvivo.CancerRes. 2007;67:5371–9.
18.HeB,ReguartN,YouL,MazieresJ,XuZ,LeeAY,etal. BlockadeofWnt-1signalinginducesapoptosisinhuman colorectalcancercellscontainingdownstreammutations. Oncogene.2005;24:3054–8.
19.BadiglianFilhoL,OshimaCT,deOliveiraLimaF,DeOliveira CostaH,DeSousaDamiãoR,GomesTS,etal.Canonicaland noncanonicalWntpathway:acomparisonamongnormal
ovary,benignovariantumorandovariancancer.OncolRep. 2009;21:313–20.
20.KrajewskaM,KrajewskiS,EpsteinJI,ShabaikA,SauvageotJ, SongK,etal.Immunohistochemicalanalysisofbcl-2,bax, bcl-X,andmcl-1expressioninprostatecancers.AmJPathol. 1996;148:1567–76.
21.TNM7thedition(2010).www.uicc.org/uiccold/resources/tnm
22.DimitriadisA,VincanE,MohammedIM,RoczoNN,Phillips WA,Baindur-HudsonS.ExpressionofWntgenesinhuman coloncancers.CancerLett.2001;166:185–91.
23.StanczakA,StecR,BodnarL,OlszewskiW,CichowiczM, KozlowskiW,etal.PrognosticsignificanceofWnt-1,
-cateninanE-caherinexpressioninadvancedcolorectal carcinoma.PatholOncolRes.2011;17:955–63.
24.DejmekJ,DejmekA,SäfholmA,SjölanderA,AndersonT. Wnt-5aproteinexpressioninprimaryDukesBcoloncancers identifiesassubgroupofpatientswithgoodprognosis. CancerRes.2005;65:9142–6.
25.SmithK,BuiTD,PoulsonR,KaklamanisWilliansG,HarrisA. Up-regulationofmacrophagewntgeneexpressionin adenoma-carcinomaprogressionofhumancolorectalcancer. BrJCancer.1999;81:496–502.
26.GilesRH,vanEsJH,CleversH.CaughtupinaWntstorm:Wnt signalingincancer.BiochimBiophysActa.2003;1653:1–24.
27.YouXJ,BryantPJ,JurnakF,HolocombeRF.ExpressionofWnt pathwaycomponentsfrizzledanddisheveledincoloncancer arisinginpatientswithinflammatoryboweldisease.Oncol Rep.2007;18:691–4.
28.HughesTA,BradyHJ.Regulationofaxin2expressionatthe levelsoftranscription,translationandproteinstabilityin lungandcoloncancer.CancerLett.2006;233:338–44.
29.JinLH,ShaoQJ,LuoW,YeZyLiQ,LinSC.Detectionofpoint mutationsoftheaxin1geneincolorectalcancers.IntJ Cancer.2003;107:696–9.